Memorial Sloan Kettering Cancer Center is recruiting patients for the clinical trial of an acupuncture study for prostate cancer survivors with rinary Issues.
The purpose of this study is to test whether acupuncture can improve nocturia in prostate cancer survivors. This is the first time acupuncture is being studied for nocturia in prostate cancer survivors. Researchers will see if acupuncture is a practical treatment option for prostate cancer survivors with nocturia. The study will also look at the effect acupuncture has on nocturia and other symptoms prostate cancer survivors experience such as insomnia, hot flashes, anxiety, depression, tiredness (fatigue), sexual dysfunction, and cognitive (mental) difficulties.
The indicative completion of the clinical trial will be expected in September 2024.
The study will take place at several locations in New Jersey and New York states, the USA. Among the main inclusion criteria are: adults 18 or older with prior PC diagnosis and undetectable PSA, clinically meaningful nocturia, defined as ≥2 nocturia episodes every night for the past month. For the complete list of the inclusion and exclusion criteria, as well as for the locations and contact details visit: https://ichgcp.net/clinical-trials-registry/NCT05540392.